IRCT20210310050660N2尚未招募3 期
The effect of cannabidiol on positive symptoms in schizophrenic patients
适应症
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- no limit 至 no limit（—）
- 性别
- All
入选标准
- •All patients with schizophrenia according to Diagnostic and Statistical Manual of Mental Disorders (DSM–5) criteria
- •Hospitalized in 22 Bahman Hospital in Qazvin
- •Candidate for treatment only with rispidone as an antipsychotic
- •Patient and legal guardian willingness to enter the study
- •Positive and Negative Syndrome Scale (PANSS) score over 60 When entering the study
- •Absence of cognitive disorders
- •Lack of drug resistance
排除标准
- •Breastfeeding and pregnancy or desire to conceive within 3 months after completion of the plan.
- •Consumption of stimulants and hallucinogens and cannabis
- •Patients with schizophrenia without positive symptoms
- •candidate for Electroconvulsive Therapy (ECT)
研究者
相似试验
招募中
3 期
Effects of Inclusion of Cannabidiol in the Usual Treatment of Obsessive Compulsive DisorderObsessive-compulsive disorderRBR-467ksmbFaculdade de Medicina de Ribeirão Preto - Universidade de São Paulo
已完成
不适用
Acute and chronic influences of cannabidiol on the ability to regenerate after strength and endurance trainingMuscle damage: CK and MyoInflammation: Il6 and Il 10DRKS00018770Deutsche Sporthochschule Köln, Institut für Kreislaufforschung und Sportmedizin, Abteilung 2 Molekulare und zelluläre Sportmedizin - Zentrum für präventive Doping Forschung26
尚未招募
4 期
Initial study of the effects of cannabidiol in patients with generalized anxiety compared to the effects of an anxiolytic (clonazepan)ervous system diseaseMental and behavioral disordersgeneralized anxietyF41.1RBR-2fw8kgFaculdade de Medicina de Ribeirão Preto - USP
招募中
2 期
The Effects of Cannabidiol (CBD) on Affective and Physiological Responses to Exercise in Healthy Endurance-Trained RunnersMetabolic DisordersMetabolic and Endocrine - Metabolic disordersACTRN12622000717752niversity of Sydney25
招募中
3 期
Cannabidiol for At Risk for psychosis Youthltra-High Risk of PsychosisUltra-High Risk of PsychosisMental Health - Psychosis and personality disordersACTRN12621000349842Orygen405